medical comorbidities - Page 1

Clinical Update

The Medical Evaluation of Anorexia

February 1, 2023

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.
Garrett Rossi, MD. Adult psychiatrist, AtlantiCare Regional Medical Center, Pomona, NJ.

Dr. Aiken and Dr. Rossi have no financial relationships with companies related to this material.

When do you order labs, how do you weight patients, and what signs and symptoms should prompt a higher level of care?

Clinical Update

Anorexia: An Update for the Psychopharmacologist

January 31, 2023

Chris Aiken, MD and Garrett Rossi, MD.

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.
Garrett Rossi, MD. Adult psychiatrist, AtlantiCare Regional Medical Center, Pomona, NJ.

Dr. Aiken and Dr. Rossi have no financial relationships with companies related to this material.

A half-dozen reviews have concluded that no medication is effective for anorexia. We agree, but they may have overlooked a common supplement with evidence to help: Zinc.

Should Prolonged Abstinence From Alcohol Be Required Before Liver Transplant?

July 1, 2022

Sonya Bakshi, MD and Deepti Anbarasan, MD.

Sonya Bakshi, MD, and Deepti Anbarasan, MD.

Dr. Bakshi and Dr. Anbarasan, authors for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

Patients with alcohol-associated liver disease have traditionally needed to demonstrate an ability to refrain from drinking for 6 months before being deemed eligible for a liver transplant, despite the absence of research findings to support this requirement. Findings from this retrospective study show that a waiting period is not associated with improved outcomes.

Hypothyroidism and Depression: Just How Related Are They?

June 1, 2022

Jason Mallo, DO

C. Jason Mallo, DO. Dr. Mallo has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

A landmark study puts a spotlight on whether patients can successfully taper off their antidepressant without relapsing.